CELLECTIS Shareholders Meeting December 22, 2023
Vote Results
Extraordinary Resolutions
NB | Resolution | Result | For | Against | Vote withhold | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | |
share capital | voting | |||||||||||
represented by the | rights | |||||||||||
represented by | rights | |||||||||||
votes cast | ||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | ||||||
Creation of a class of preferred shares referred to as "Class A preferred shares" convertible into ordinary shares (the "A Shares") - determination of the specific rights attached to the A Shares - corresponding amendment to the bylaws
1 | |||||||||||||||
1 | Carried | 26 188 875 | 99,65 % | 92 063 | 0,35 % | 35 416 | - | 26 280 938 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | ||
Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 500,000, through the issuance of a maximum of 10,000,000 A Shares, with cancellation of the shareholders' preferential subscription rights in favor of a named person | |||||||||||||||
2 | |||||||||||||||
2 | Carried | 26 171 469 | 99,55 % | 118 145 | 0,45 % | 26 740 | - | 26 289 614 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | ||
Creation of a class of preferred shares referred to as "Class B preferred shares" convertible into ordinary shares (the "B Shares") - determination of the specific rights attached to the B Shares - corresponding amendment to the bylaws | |||||||||||||||
3 | |||||||||||||||
3 | Carried | 26 189 117 | 99,63 % | 97 794 | 0,37 % | 29 443 | - | 26 286 911 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | ||
Delegation of authority to the board of directors to increase the share capital by a maximum nominal amount of EUR 900,000, through the issuance of a maximum of 18,000,000 B Shares, with cancellation of the shareholders' preferential subscription rights in favor of a named person | |||||||||||||||
4 | |||||||||||||||
4 | Carried | 26 198 396 | 99,63 % | 96 411 | 0,37 % | 21 547 | - | 26 294 807 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | ||
Cancellation of the shareholders' preferential subscription rights in favor of AstraZeneca Holdings B.V. | |||||||||||||||
5 | |||||||||||||||
5 | Carried | 26 205 300 | 99,67 % | 88 077 | 0,33 % | 22 977 | - | 26 293 377 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | ||
Delegation of authority to the board of directors to carry out a share capital increase reserved for members of a company savings plan set up in accordance with Articles L. 3332-1 et seq. of the French Labor Code | |||||||||||||||
6 |
6
Rejected
6 297 651
23,95 %
19 998 142
76,05 %
20 561
-
26 295 793
21 466 266
29,917 %
0
0
29,917 %
1/2
CELLECTIS Shareholders Meeting December 22, 2023
VOTING RESULTS
Ordinary Resolutions
NB | Resolution | Result | For | Against | Vote | Total votes | Shares | Percentage of the | Out of vote | Null voting | Quorum | |
share capital | voting | |||||||||||
withhold | represented by the | rights | ||||||||||
represented by | rights | |||||||||||
votes cast | ||||||||||||
Votes | % | Votes | % | Votes | % | the votes cast | ||||||
Appointment of a director (Mr. Marc Dunoyer) subject to condition precedent
7
7 | Carried | 25 945 461 | 98,65 % | 354 396 | 1,35 % | 16 497 | - | 26 299 857 | 21 466 266 | 29,917 % | 0 | 0 | 29,917 % | |
Appointment of a director (Mr. Tyrell Rivers) subject to condition precedent
8
8
Carried
26 032 194
99,03 %
253 663
0,97 %
30 497
-
26 285 857
21 466 266
29,917 %
0
0
29,917 %
2/2
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Cellectis SA published this content on 22 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 December 2023 16:47:38 UTC.